Literature DB >> 9152419

Duration of the foot-and-mouth disease virus antibody response in mice is closely related to the presence of antigen-specific presenting cells.

A Wigdorovitz1, P Zamorano, F M Fernández, O López, M Prato-Murphy, C Carrillo, A M Sadir, M V Borca.   

Abstract

Natural and experimental hosts infected with foot-and-mouth disease virus (FMDV) develop a long-lasting immune response that is closely related to the presence of anti-FMDV antibodies (Ab). We show here that spleen cells from animals which had been infected 3 or more months previously induced an anti-FMDV-Ab response in untreated animals which lasted more than 210 days after cell transfer. Persistence of infectious virus was excluded since virus isolation or detection of the viral genome by PCR in donor splenocytes were consistently negative. The role of antigen presentation (AP) in this phenomenon was studied in vivo by using irradiated splenocytes from virus-sensitized donor mice. Although these irradiated cells were unable to induce anti-FMDV-Ab in normal or irradiated recipient mice, they elicited a strong secondary reaction in FMDV-pre-sensitized recipients. The presence of AP cells (APC) presenting FMDV epitopes (FMDV/APC) was also analysed in mice sensitized to FMDV in different ways. A close correlation between FMDV/APC and the presence of anti-FMDV-Ab was found in infected mice as well as in mice immunized with different doses of inactivated virus, with or without adjuvants. Experiments in vivo and in vitro showed that the APC activity can be specifically blocked with either anti-MHC class II monoclonal antibody or anti-FMDV antiserum, and is dependent on the presence of T cell function. These results strongly suggest that persistent FMDV/APC are responsible for the existence and maintenance of an anti-virus immune response regardless of the immunization method used.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9152419     DOI: 10.1099/0022-1317-78-5-1025

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  4 in total

1.  A comparison of methods for measuring the antibody response in mice and cattle following vaccination against foot and mouth disease.

Authors:  M J Dus Santos; A Wigdorovitz; E Maradei; O Periolo; E Smitsaart; M V Borca; A M Sadir
Journal:  Vet Res Commun       Date:  2000-05       Impact factor: 2.459

2.  Systemic Foot-and-Mouth Disease Vaccination in Cattle Promotes Specific Antibody-Secreting Cells at the Respiratory Tract and Triggers Local Anamnestic Responses upon Aerosol Infection.

Authors:  J Pega; S Di Giacomo; D Bucafusco; J M Schammas; D Malacari; F Barrionuevo; A V Capozzo; L L Rodríguez; M V Borca; M Pérez-Filgueira
Journal:  J Virol       Date:  2015-07-08       Impact factor: 5.103

3.  The early protective thymus-independent antibody response to foot-and-mouth disease virus is mediated by splenic CD9+ B lymphocytes.

Authors:  Matias Ostrowski; Monica Vermeulen; Osvaldo Zabal; Patricia I Zamorano; Ana M Sadir; Jorge R Geffner; Osvaldo J Lopez
Journal:  J Virol       Date:  2007-06-13       Impact factor: 5.103

Review 4.  Laboratory animal models to study foot-and-mouth disease: a review with emphasis on natural and vaccine-induced immunity.

Authors:  Mohammed Habiela; Julian Seago; Eva Perez-Martin; Ryan Waters; Miriam Windsor; Francisco J Salguero; James Wood; Bryan Charleston; Nicholas Juleff
Journal:  J Gen Virol       Date:  2014-07-07       Impact factor: 3.891

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.